quantisnow
FeedTopReportsPricing
⌘K
Live feed
18:05:01·43d
INSIDERFiling
Quest Diagnostics Incorporated logo

SEC Form 4 filed by Quest Diagnostics Incorporated

DGX· Quest Diagnostics Incorporated
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • DGX
    Quest Diagnostics Incorporated
    Health Care

Recent analyst ratings

  • Jan 30UpdateBarclays$210.00
  • Aug 25UpdateRobert W. Baird$194.00
  • Apr 2UpdateRedburn Atlantic$195.00
  • Mar 4UpdateCitigroup$185.00
  • Jan 6UpdateLeerink Partners$174.00
  • Dec 17UpdateMorgan Stanley$172.00

Related

  • SEC1d
    SEC Form 10-Q filed by Quest Diagnostics Incorporated
  • SEC2d
    Quest Diagnostics Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR2d
    Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026
  • PR7d
    City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers
  • SEC17d
    SEC Form DEFA14A filed by Quest Diagnostics Incorporated
  • SEC17d
    SEC Form DEF 14A filed by Quest Diagnostics Incorporated
  • INSIDER21d
    SEC Form 4 filed by Wentworth Timothy C
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Quest Diagnostics Incorporated
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022